Miriam Guggenheim spoke at the Legal, Regulatory, and Compliance Forum on Dietary Supplements and is quoted in a NutraIngredients article. Guggenheim said that a popular question she gets from industry clients around new dietary ingredients (NDIs) is whether or not an ingredient can be classified as ‘old.’ Despite lobbying from trade associations, Guggenheim said an ODI list from the FDA won’t likely happen. “My predictions is that, despite the attention, this is too big a bridge to cross at this stage,” she said. “And with the absence of significant safety concerns, this distinction doesn’t seem to be either a major priority for FDA at this time or a good use of the agency’s resources, so I’m not holding my breath for an ODI list.”